A company with breakthrough potential in Alzheimer's... and the price is being dictated by 5-share
trades. This isn't normal. It's not efficient. It's not transparent.
It's a theatre of illusion -- where bots run the show, the last trade trumps real volume, and retail
confidence erodes in slow motion.
The ASX allows it.
The algorithms exploit it.
And the story is being rewritten one 10-cent trade at a time -- not by science or progress, but bysystems designed to suppress and accumulate, not reflect value.
Meanwhile:
- No word on trial site recruitment or momentum
- No post-BIO update or engagement with shareholders
- No challenge to the suppression behavior
- No attempt to restore transparency or confidence
And yet -- through all this -- the science hasn't changed.
The hope is still real.
The potential is still massive.
What's missing is not belief in the drug -- it's belief that we're in a fair and open market.
(20min delay)